Global Biopharmaceutical Fermentation Systems Market: Industry Analysis and Forecast (2019-2027) – by Product, Application, End-user and Region.

Global Biopharmaceutical Fermentation Systems Market was value US$ XX Mn in 2019 and is expected to reach US$ XX Mn by 2027, at a CAGR of XX % during forecast period. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. To know about the Research Methodology:-Request Free Sample Report An increase in research and development activities, technological advancements, growth in awareness and demand for biotech based drugs, and new product launches are some of the factors likely to drive the biopharmaceutical fermentation systems market globally. Growing global population with several genetic disorders and deficiencies has increased the demand for recombinant drugs or biopharmaceuticals such as proteins, enzymes, etc., that in turn has boosted the demand of biopharmaceutical fermentation systems. Major Pharma companies are investing huge amount of money in research and developments sector as well as biological manufacturing plants to meet the global demand of biopharmaceuticals, additionally government institutes are also investing the major share of healthcare expenditure on the production of biological drugs, all these factors are combinedly contributing to the growth of biopharmaceutical fermentation systems market. Additionally, high revenue generation of blockbuster biological drugs like Humira, Rituxan, Lantus, Avastin, Herceptin, and Remicade are gaining power from many biologics manufacturers. However, the high cost related with the manufacture and stringent regulatory requirements is expected to hamper the growth of the biopharmaceutical contract manufacturing market. Innovation to make efficient and cost-effective fermentation systems to make it feasible for small scale industries can provide better opportunities for the market. The report delivers current and future trends that are outlined to determine the overall attractiveness and to single out profitable trends to gain a stronger foothold in the Biopharmaceutical Fermentation Systems industry. Based on application, the recombinant proteins segment held a major market share in 2018, because of, high reliance on microbial systems for recombinant protein production contributed toward the leading share of the segment. As a result of an increase in investment in research activities and the introduction of new protein, therapeutics have significantly contributed to the development of recombinant therapeutic antibodies and proteins. Region-wise, North America dominates the market in terms of revenue followed by Europe. Well established healthcare infrastructure, presence of key players and rising industrialization are some factors contributing to the growth of these regions. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding the global Biopharmaceutical Fermentation Systems market dynamics, structure by identifying and analysing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the global gram Biopharmaceutical Fermentation Systems market.

Scope of Global Biopharmaceutical Fermentation Systems Market: Inquire before buying

Global Biopharmaceutical Fermentation Systems Market, by Product

• Fermenters • Bioprocess Analyzers • Process Monitoring Devices • Culture & Media Preparation • Culture Media, Buffers & Inducers • Others

Global Biopharmaceutical Fermentation Systems Market, by Application

• Recombinant Proteins • Monoclonal Antibodies • Antibiotics • Probiotics • Others

Global Biopharmaceutical Fermentation Systems Market, by End-user

• Biopharmaceutical companies • Contract manufacturing organizations • Contract research organizations • Academic research institutes • Food industry • Others.

Global Biopharmaceutical Fermentation Systems Market, by Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Key players operating in the Global Biopharmaceutical Fermentation Systems Market

• GE Healthcare • Thermo Fisher Scientific • Danaher Corporation • Sartorius StedimBiotech • Merck • Eppendorf • Roche • Nova Biomedicals • Lonza • Becton • Dickinson and Company • GEA • F. Hoffmann-La Roche Ltd • AntoXa Corporation • BioPharm Process Associates, LLC • ZETA GmbH • 3M Company • Agilent Technologies, Inc. • Bio-Rad Laboratories, Inc. • Repligen Corporation

Global Biopharmaceutical Fermentation Systems Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Biopharmaceutical Fermentation Systems Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecast 6.1. Global Biopharmaceutical Fermentation Systems Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecast, by Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product 7.4. Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product 7.5. Global Biopharmaceutical Fermentation Systems Market Analysis, by Product 7.6. Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Product 8. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecast, by Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application 8.4. Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application 8.5. Global Biopharmaceutical Fermentation Systems Market Analysis, by Application 8.6. Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application 9. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecast, by End-user 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user 9.4. Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user 9.5. Global Biopharmaceutical Fermentation Systems Market Analysis, by End-user 9.6. Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user 10. Global Biopharmaceutical Fermentation Systems Market Analysis, by Region 10.1. Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Region 10.2. Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Region 10.3. Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Region 11. North America Biopharmaceutical Fermentation Systems Market Analysis 11.1. Key Findings 11.2. North America Biopharmaceutical Fermentation Systems Market Overview 11.3. North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product 11.4. North America Biopharmaceutical Fermentation Systems Market Forecast, by Product 11.4.1. Fermenters 11.4.2. Bioprocess Analyzers 11.4.3. Process Monitoring Devices 11.4.4. Culture & Media Preparation 11.4.5. Culture Media, Buffers & Inducers 11.4.6. Others 11.5. North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application 11.6. North America Biopharmaceutical Fermentation Systems Market Forecast, by Application 11.6.1. Recombinant Proteins 11.6.2. Monoclonal Antibodies 11.6.3. Antibiotics 11.6.4. Probiotics 11.6.5. Others 11.7. North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user 11.8. North America Biopharmaceutical Fermentation Systems Market Forecast, by End-user 11.8.1. Biopharmaceutical companies 11.8.2. Contract manufacturing organizations 11.8.3. Contract research organizations 11.8.4. Academic research institutes 11.8.5. Food industry 11.8.6. Others 11.9. North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country 11.10. North America Biopharmaceutical Fermentation Systems Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Biopharmaceutical Fermentation Systems Market Analysis, by Country 11.12. U.S. Biopharmaceutical Fermentation Systems Market Forecast, by Product 11.12.1. Fermenters 11.12.2. Bioprocess Analyzers 11.12.3. Process Monitoring Devices 11.12.4. Culture & Media Preparation 11.12.5. Culture Media, Buffers & Inducers 11.12.6. Others 11.13. U.S. Biopharmaceutical Fermentation Systems Market Forecast, by Application 11.13.1. Recombinant Proteins 11.13.2. Monoclonal Antibodies 11.13.3. Antibiotics 11.13.4. Probiotics 11.13.5. Others 11.14. U.S. Biopharmaceutical Fermentation Systems Market Forecast, by End-user 11.14.1. Biopharmaceutical companies 11.14.2. Contract manufacturing organizations 11.14.3. Contract research organizations 11.14.4. Academic research institutes 11.14.5. Food industry 11.14.6. Others 11.15. Canada Biopharmaceutical Fermentation Systems Market Forecast, by Product 11.15.1. Fermenters 11.15.2. Bioprocess Analyzers 11.15.3. Process Monitoring Devices 11.15.4. Culture & Media Preparation 11.15.5. Culture Media, Buffers & Inducers 11.15.6. Others 11.16. Steel Canada Biopharmaceutical Fermentation Systems Market Forecast, by Application 11.16.1. Recombinant Proteins 11.16.2. Monoclonal Antibodies 11.16.3. Antibiotics 11.16.4. Probiotics 11.16.5. Others 11.17. Canada Biopharmaceutical Fermentation Systems Market Forecast, by End-user 11.17.1. Biopharmaceutical companies 11.17.2. Contract manufacturing organizations 11.17.3. Contract research organizations 11.17.4. Academic research institutes 11.17.5. Food industry 11.17.6. Others 11.18. North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis 11.18.1. By Product 11.18.2. By Application 11.18.3. By End-user 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Biopharmaceutical Fermentation Systems Market Analysis 12.1. Key Findings 12.2. Europe Biopharmaceutical Fermentation Systems Market Overview 12.3. Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product 12.4. Europe Biopharmaceutical Fermentation Systems Market Forecast, by Product 12.4.1. Fermenters 12.4.2. Bioprocess Analyzers 12.4.3. Process Monitoring Devices 12.4.4. Culture & Media Preparation 12.4.5. Culture Media, Buffers & Inducers 12.4.6. Others 12.5. Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application 12.6. Europe Biopharmaceutical Fermentation Systems Market Forecast, by Application 12.6.1. Recombinant Proteins 12.6.2. Monoclonal Antibodies 12.6.3. Antibiotics 12.6.4. Probiotics 12.6.5. Others 12.7. Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user 12.8. Europe Biopharmaceutical Fermentation Systems Market Forecast, by End-user 12.8.1. Biopharmaceutical companies 12.8.2. Contract manufacturing organizations 12.8.3. Contract research organizations 12.8.4. Academic research institutes 12.8.5. Food industry 12.8.6. Others 12.9. Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country 12.10. Europe Biopharmaceutical Fermentation Systems Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Biopharmaceutical Fermentation Systems Market Analysis, by Country 12.12. Germany Biopharmaceutical Fermentation Systems Market Forecast, by Product 12.12.1. Fermenters 12.12.2. Bioprocess Analyzers 12.12.3. Process Monitoring Devices 12.12.4. Culture & Media Preparation 12.12.5. Culture Media, Buffers & Inducers 12.12.6. Others 12.13. Germany Biopharmaceutical Fermentation Systems Market Forecast, by Application 12.13.1. Recombinant Proteins 12.13.2. Monoclonal Antibodies 12.13.3. Antibiotics 12.13.4. Probiotics 12.13.5. Others 12.14. Germany Biopharmaceutical Fermentation Systems Market Forecast, by End-user 12.14.1. Biopharmaceutical companies 12.14.2. Contract manufacturing organizations 12.14.3. Contract research organizations 12.14.4. Academic research institutes 12.14.5. Food industry 12.14.6. Others 12.15. U.K. Biopharmaceutical Fermentation Systems Market Forecast, by Product 12.15.1. Fermenters 12.15.2. Bioprocess Analyzers 12.15.3. Process Monitoring Devices 12.15.4. Culture & Media Preparation 12.15.5. Culture Media, Buffers & Inducers 12.15.6. Others 12.16. U.K. Biopharmaceutical Fermentation Systems Market Forecast, by Application 12.16.1. Recombinant Proteins 12.16.2. Monoclonal Antibodies 12.16.3. Antibiotics 12.16.4. Probiotics 12.16.5. Others 12.17. U.K. Biopharmaceutical Fermentation Systems Market Forecast, by End-user 12.17.1. Biopharmaceutical companies 12.17.2. Contract manufacturing organizations 12.17.3. Contract research organizations 12.17.4. Academic research institutes 12.17.5. Food industry 12.17.6. Others 12.18. France Biopharmaceutical Fermentation Systems Market Forecast, by Product 12.18.1. Fermenters 12.18.2. Bioprocess Analyzers 12.18.3. Process Monitoring Devices 12.18.4. Culture & Media Preparation 12.18.5. Culture Media, Buffers & Inducers 12.18.6. Others 12.19. France Biopharmaceutical Fermentation Systems Market Forecast, by Application 12.19.1. Recombinant Proteins 12.19.2. Monoclonal Antibodies 12.19.3. Antibiotics 12.19.4. Probiotics 12.19.5. Others 12.20. France Biopharmaceutical Fermentation Systems Market Forecast, by End-user 12.20.1. Biopharmaceutical companies 12.20.2. Contract manufacturing organizations 12.20.3. Contract research organizations 12.20.4. Academic research institutes 12.20.5. Food industry 12.20.6. Others 12.21. Italy Biopharmaceutical Fermentation Systems Market Forecast, by Product 12.21.1. Fermenters 12.21.2. Bioprocess Analyzers 12.21.3. Process Monitoring Devices 12.21.4. Culture & Media Preparation 12.21.5. Culture Media, Buffers & Inducers 12.21.6. Others 12.22. Italy Biopharmaceutical Fermentation Systems Market Forecast, by Application 12.22.1. Recombinant Proteins 12.22.2. Monoclonal Antibodies 12.22.3. Antibiotics 12.22.4. Probiotics 12.22.5. Others 12.23. Italy Biopharmaceutical Fermentation Systems Market Forecast, by End-user 12.23.1. Biopharmaceutical companies 12.23.2. Contract manufacturing organizations 12.23.3. Contract research organizations 12.23.4. Academic research institutes 12.23.5. Food industry 12.23.6. Others 12.24. Spain Biopharmaceutical Fermentation Systems Market Forecast, by Product 12.24.1. Fermenters 12.24.2. Bioprocess Analyzers 12.24.3. Process Monitoring Devices 12.24.4. Culture & Media Preparation 12.24.5. Culture Media, Buffers & Inducers 12.24.6. Others 12.25. Spain Biopharmaceutical Fermentation Systems Market Forecast, by Application 12.25.1. Recombinant Proteins 12.25.2. Monoclonal Antibodies 12.25.3. Antibiotics 12.25.4. Probiotics 12.25.5. Others 12.26. Spain Biopharmaceutical Fermentation Systems Market Forecast, by End-user 12.26.1. Biopharmaceutical companies 12.26.2. Contract manufacturing organizations 12.26.3. Contract research organizations 12.26.4. Academic research institutes 12.26.5. Food industry 12.26.6. Others 12.27. Rest of Europe Biopharmaceutical Fermentation Systems Market Forecast, by Product 12.27.1. Fermenters 12.27.2. Bioprocess Analyzers 12.27.3. Process Monitoring Devices 12.27.4. Culture & Media Preparation 12.27.5. Culture Media, Buffers & Inducers 12.27.6. Others 12.28. Rest of Europe Biopharmaceutical Fermentation Systems Market Forecast, by Application 12.28.1. Recombinant Proteins 12.28.2. Monoclonal Antibodies 12.28.3. Antibiotics 12.28.4. Probiotics 12.28.5. Others 12.29. Rest Of Europe Biopharmaceutical Fermentation Systems Market Forecast, by End-user 12.29.1. Biopharmaceutical companies 12.29.2. Contract manufacturing organizations 12.29.3. Contract research organizations 12.29.4. Academic research institutes 12.29.5. Food industry 12.29.6. Others 12.30. Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis 12.30.1. By Product 12.30.2. By Application 12.30.3. By End-user 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Biopharmaceutical Fermentation Systems Market Analysis 13.1. Key Findings 13.2. Asia Pacific Biopharmaceutical Fermentation Systems Market Overview 13.3. Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product 13.4. Asia Pacific Biopharmaceutical Fermentation Systems Market Forecast, by Product 13.4.1. Fermenters 13.4.2. Bioprocess Analyzers 13.4.3. Process Monitoring Devices 13.4.4. Culture & Media Preparation 13.4.5. Culture Media, Buffers & Inducers 13.4.6. Others 13.5. Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application 13.6. Asia Pacific Biopharmaceutical Fermentation Systems Market Forecast, by Application 13.6.1. Recombinant Proteins 13.6.2. Monoclonal Antibodies 13.6.3. Antibiotics 13.6.4. Probiotics 13.6.5. Others 13.7. Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user 13.8. Asia Pacific Biopharmaceutical Fermentation Systems Market Forecast, by End-user 13.8.1. Biopharmaceutical companies 13.8.2. Contract manufacturing organizations 13.8.3. Contract research organizations 13.8.4. Academic research institutes 13.8.5. Food industry 13.8.6. Others 13.9. Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country 13.10. Asia Pacific Biopharmaceutical Fermentation Systems Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Biopharmaceutical Fermentation Systems Market Analysis, by Country 13.12. China Biopharmaceutical Fermentation Systems Market Forecast, by Product 13.12.1. Fermenters 13.12.2. Bioprocess Analyzers 13.12.3. Process Monitoring Devices 13.12.4. Culture & Media Preparation 13.12.5. Culture Media, Buffers & Inducers 13.12.6. Others 13.13. China Biopharmaceutical Fermentation Systems Market Forecast, by Application 13.13.1. Recombinant Proteins 13.13.2. Monoclonal Antibodies 13.13.3. Antibiotics 13.13.4. Probiotics 13.13.5. Others 13.14. China Biopharmaceutical Fermentation Systems Market Forecast, by End-user 13.14.1. Biopharmaceutical companies 13.14.2. Contract manufacturing organizations 13.14.3. Contract research organizations 13.14.4. Academic research institutes 13.14.5. Food industry 13.14.6. Others 13.15. India Biopharmaceutical Fermentation Systems Market Forecast, by Product 13.15.1. Fermenters 13.15.2. Bioprocess Analyzers 13.15.3. Process Monitoring Devices 13.15.4. Culture & Media Preparation 13.15.5. Culture Media, Buffers & Inducers 13.15.6. Others 13.16. India Biopharmaceutical Fermentation Systems Market Forecast, by Application 13.16.1. Recombinant Proteins 13.16.2. Monoclonal Antibodies 13.16.3. Antibiotics 13.16.4. Probiotics 13.16.5. Others 13.17. India Biopharmaceutical Fermentation Systems Market Forecast, by End-user 13.17.1. Biopharmaceutical companies 13.17.2. Contract manufacturing organizations 13.17.3. Contract research organizations 13.17.4. Academic research institutes 13.17.5. Food industry 13.17.6. Others 13.18. Japan Biopharmaceutical Fermentation Systems Market Forecast, by Product 13.18.1. Fermenters 13.18.2. Bioprocess Analyzers 13.18.3. Process Monitoring Devices 13.18.4. Culture & Media Preparation 13.18.5. Culture Media, Buffers & Inducers 13.18.6. Others 13.19. Japan Biopharmaceutical Fermentation Systems Market Forecast, by Application 13.19.1. Recombinant Proteins 13.19.2. Monoclonal Antibodies 13.19.3. Antibiotics 13.19.4. Probiotics 13.19.5. Others 13.20. Japan Biopharmaceutical Fermentation Systems Market Forecast, by End-user 13.20.1. Biopharmaceutical companies 13.20.2. Contract manufacturing organizations 13.20.3. Contract research organizations 13.20.4. Academic research institutes 13.20.5. Food industry 13.20.6. Others 13.21. ASEAN Biopharmaceutical Fermentation Systems Market Forecast, by Product 13.21.1. Fermenters 13.21.2. Bioprocess Analyzers 13.21.3. Process Monitoring Devices 13.21.4. Culture & Media Preparation 13.21.5. Culture Media, Buffers & Inducers 13.21.6. Others 13.22. ASEAN Biopharmaceutical Fermentation Systems Market Forecast, by Application 13.22.1. Recombinant Proteins 13.22.2. Monoclonal Antibodies 13.22.3. Antibiotics 13.22.4. Probiotics 13.22.5. Others 13.23. ASEAN Biopharmaceutical Fermentation Systems Market Forecast, by End-user 13.23.1. Biopharmaceutical companies 13.23.2. Contract manufacturing organizations 13.23.3. Contract research organizations 13.23.4. Academic research institutes 13.23.5. Food industry 13.23.6. Others 13.24. Rest of Asia Pacific Biopharmaceutical Fermentation Systems Market Forecast, by Product 13.24.1. Fermenters 13.24.2. Bioprocess Analyzers 13.24.3. Process Monitoring Devices 13.24.4. Culture & Media Preparation 13.24.5. Culture Media, Buffers & Inducers 13.24.6. Others 13.25. Rest of Asia Pacific Biopharmaceutical Fermentation Systems Market Forecast, by Application 13.25.1. Recombinant Proteins 13.25.2. Monoclonal Antibodies 13.25.3. Antibiotics 13.25.4. Probiotics 13.25.5. Others 13.26. Rest of Asia Pacific Biopharmaceutical Fermentation Systems Market Forecast, by End-user 13.26.1. Biopharmaceutical companies 13.26.2. Contract manufacturing organizations 13.26.3. Contract research organizations 13.26.4. Academic research institutes 13.26.5. Food industry 13.26.6. Others 13.27. Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis 13.27.1. By Product 13.27.2. By Application 13.27.3. By End-user 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Biopharmaceutical Fermentation Systems Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Biopharmaceutical Fermentation Systems Market Overview 14.3. Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product 14.4. Middle East & Africa Biopharmaceutical Fermentation Systems Market Forecast, by Product 14.4.1. Fermenters 14.4.2. Bioprocess Analyzers 14.4.3. Process Monitoring Devices 14.4.4. Culture & Media Preparation 14.4.5. Culture Media, Buffers & Inducers 14.4.6. Others 14.5. Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application 14.6. Middle East & Africa Biopharmaceutical Fermentation Systems Market Forecast, by Application 14.6.1. Recombinant Proteins 14.6.2. Monoclonal Antibodies 14.6.3. Antibiotics 14.6.4. Probiotics 14.6.5. Others 14.7. Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user 14.8. Middle East & Africa Biopharmaceutical Fermentation Systems Market Forecast, by End-user 14.8.1. Biopharmaceutical companies 14.8.2. Contract manufacturing organizations 14.8.3. Contract research organizations 14.8.4. Academic research institutes 14.8.5. Food industry 14.8.6. Others 14.9. Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country 14.10. Middle East & Africa Biopharmaceutical Fermentation Systems Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Biopharmaceutical Fermentation Systems Market Analysis, by Country 14.12. GCC Biopharmaceutical Fermentation Systems Market Forecast, by Product 14.12.1. Fermenters 14.12.2. Bioprocess Analyzers 14.12.3. Process Monitoring Devices 14.12.4. Culture & Media Preparation 14.12.5. Culture Media, Buffers & Inducers 14.12.6. Others 14.13. GCC Biopharmaceutical Fermentation Systems Market Forecast, by Application 14.13.1. Recombinant Proteins 14.13.2. Monoclonal Antibodies 14.13.3. Antibiotics 14.13.4. Probiotics 14.13.5. Others 14.14. GCC Biopharmaceutical Fermentation Systems Market Forecast, by End-user 14.14.1. Biopharmaceutical companies 14.14.2. Contract manufacturing organizations 14.14.3. Contract research organizations 14.14.4. Academic research institutes 14.14.5. Food industry 14.14.6. Others 14.15. South Africa Biopharmaceutical Fermentation Systems Market Forecast, by Product 14.15.1. Fermenters 14.15.2. Bioprocess Analyzers 14.15.3. Process Monitoring Devices 14.15.4. Culture & Media Preparation 14.15.5. Culture Media, Buffers & Inducers 14.15.6. Others 14.16. South Africa Biopharmaceutical Fermentation Systems Market Forecast, by Application 14.16.1. Recombinant Proteins 14.16.2. Monoclonal Antibodies 14.16.3. Antibiotics 14.16.4. Probiotics 14.16.5. Others 14.17. South Africa Biopharmaceutical Fermentation Systems Market Forecast, by End-user 14.17.1. Biopharmaceutical companies 14.17.2. Contract manufacturing organizations 14.17.3. Contract research organizations 14.17.4. Academic research institutes 14.17.5. Food industry 14.17.6. Others 14.18. Rest of Middle East & Africa Biopharmaceutical Fermentation Systems Market Forecast, by Product 14.18.1. Fermenters 14.18.2. Bioprocess Analyzers 14.18.3. Process Monitoring Devices 14.18.4. Culture & Media Preparation 14.18.5. Culture Media, Buffers & Inducers 14.18.6. Others 14.19. Rest of Middle East & Africa Biopharmaceutical Fermentation Systems Market Forecast, by Application 14.19.1. Recombinant Proteins 14.19.2. Monoclonal Antibodies 14.19.3. Antibiotics 14.19.4. Probiotics 14.19.5. Others 14.20. Rest of Middle East & Africa Biopharmaceutical Fermentation Systems Market Forecast, by End-user 14.20.1. Biopharmaceutical companies 14.20.2. Contract manufacturing organizations 14.20.3. Contract research organizations 14.20.4. Academic research institutes 14.20.5. Food industry 14.20.6. Others 14.21. Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis 14.21.1. By Product 14.21.2. By Application 14.21.3. By End-user 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Biopharmaceutical Fermentation Systems Market Analysis 15.1. Key Findings 15.2. South America Biopharmaceutical Fermentation Systems Market Overview 15.3. South America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product 15.4. South America Biopharmaceutical Fermentation Systems Market Forecast, by Product 15.4.1. Fermenters 15.4.2. Bioprocess Analyzers 15.4.3. Process Monitoring Devices 15.4.4. Culture & Media Preparation 15.4.5. Culture Media, Buffers & Inducers 15.4.6. Others 15.5. South America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application 15.6. South America Biopharmaceutical Fermentation Systems Market Forecast, by Application 15.6.1. Recombinant Proteins 15.6.2. Monoclonal Antibodies 15.6.3. Antibiotics 15.6.4. Probiotics 15.6.5. Others 15.7. South America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user 15.8. South America Biopharmaceutical Fermentation Systems Market Forecast, by End-user 15.8.1. Biopharmaceutical companies 15.8.2. Contract manufacturing organizations 15.8.3. Contract research organizations 15.8.4. Academic research institutes 15.8.5. Food industry 15.8.6. Others 15.9. South America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country 15.10. South America Biopharmaceutical Fermentation Systems Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Biopharmaceutical Fermentation Systems Market Analysis, by Country 15.12. Brazil Biopharmaceutical Fermentation Systems Market Forecast, by Product 15.12.1. Fermenters 15.12.2. Bioprocess Analyzers 15.12.3. Process Monitoring Devices 15.12.4. Culture & Media Preparation 15.12.5. Culture Media, Buffers & Inducers 15.12.6. Others 15.13. Brazil Biopharmaceutical Fermentation Systems Market Forecast, by Application 15.13.1. Recombinant Proteins 15.13.2. Monoclonal Antibodies 15.13.3. Antibiotics 15.13.4. Probiotics 15.13.5. Others 15.14. Brazil Biopharmaceutical Fermentation Systems Market Forecast, by End-user 15.14.1. Biopharmaceutical companies 15.14.2. Contract manufacturing organizations 15.14.3. Contract research organizations 15.14.4. Academic research institutes 15.14.5. Food industry 15.14.6. Others 15.15. Mexico Biopharmaceutical Fermentation Systems Market Forecast, by Product 15.15.1. Fermenters 15.15.2. Bioprocess Analyzers 15.15.3. Process Monitoring Devices 15.15.4. Culture & Media Preparation 15.15.5. Culture Media, Buffers & Inducers 15.15.6. Others 15.16. Mexico Biopharmaceutical Fermentation Systems Market Forecast, by Application 15.16.1. Recombinant Proteins 15.16.2. Monoclonal Antibodies 15.16.3. Antibiotics 15.16.4. Probiotics 15.16.5. Others 15.17. Mexico Biopharmaceutical Fermentation Systems Market Forecast, by End-user 15.17.1. Biopharmaceutical companies 15.17.2. Contract manufacturing organizations 15.17.3. Contract research organizations 15.17.4. Academic research institutes 15.17.5. Food industry 15.17.6. Others 15.18. Rest of South America Biopharmaceutical Fermentation Systems Market Forecast, by Product 15.18.1. Fermenters 15.18.2. Bioprocess Analyzers 15.18.3. Process Monitoring Devices 15.18.4. Culture & Media Preparation 15.18.5. Culture Media, Buffers & Inducers 15.18.6. Others 15.19. Rest of South America Biopharmaceutical Fermentation Systems Market Forecast, by Application 15.19.1. Recombinant Proteins 15.19.2. Monoclonal Antibodies 15.19.3. Antibiotics 15.19.4. Probiotics 15.19.5. Others 15.20. Rest of South America Biopharmaceutical Fermentation Systems Market Forecast, by End-user 15.20.1. Biopharmaceutical companies 15.20.2. Contract manufacturing organizations 15.20.3. Contract research organizations 15.20.4. Academic research institutes 15.20.5. Food industry 15.20.6. Others 15.21. South America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis 15.21.1. By Product 15.21.2. By Application 15.21.3. By End-user 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. GE Healthcare 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Developing Footprint 16.3.2. Thermo Fisher Scientific 16.3.3. Danaher Corporation 16.3.4. Sartorius StedimBiotech 16.3.5. Merck 16.3.6. Eppendorf 16.3.7. Roche 16.3.8. Nova Biomedicals 16.3.9. Lonza 16.3.10. Becton 16.3.11. Dickinson and Company 16.3.12. GEA 16.3.13. F. Hoffmann-La Roche Ltd 16.3.14. AntoXa Corporation 16.3.15. BioPharm Process Associates, LLC 16.3.16. ZETA GmbH 16.3.17. 3M Company 16.3.18. Agilent Technologies, Inc. 16.3.19. Bio-Rad Laboratories, Inc. 16.3.20. Repligen Corporation 17. Primary Key Insights

About This Report

Report ID 33782
Category Biotechnology
Published Date Aug 2019
Updated Date Sep 2020
Contact Us